PATENT CLAIM ANALYSIS

Application Number: 16326976
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["546", "113000"]

Abstract:
Provided are a PDE4 inhibitor and a use thereof in the preparation of a medicament for treating PDE4 related diseases. Specifically disclosed are the compound as shown in formula (I) and a pharmaceutically acceptable salt thereof.

Claim (Index 11):
The compound or the pharmaceutically acceptable salt thereof according to  claim 1 , wherein X is selected from

Metadata:
- Claim Count in Document: 31.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16325626', '16317510', '16476797', '16087861', '15812142']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7996762601618262
- 35 USC 102 Novelty (BERT): 0.5429366697577811
- Combined Prediction Score: 0.7740023011214218
- Mean Citation Score: 372.804462
- Max Citation Score: 383.89105
- Similarity Product: 315.95126331752243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test